跳转至内容
Merck
CN
所有图片(3)

主要文件

查看所有文档

P1152

Sigma-Aldrich

聚(Ala, Glu, Lys, Tyr) 6:2:5:1 氢溴酸盐

greener alternative

Ala:Glu:Lys:Tyr (6:2:5:1), mol wt 20,000-30,000

别名:

(L-Ala, L-Glu, L-Lys, L-Tyr)n ·HBr, COP-1

登录查看公司和协议定价
所有图片(3)

About This Item

CAS号:
28704-27-0
MDL编号:
MFCD00166401
UNSPSC代码:
12352202
NACRES:
NA.26

表单

powder

质量水平

200

投料比

Ala:Glu:Lys:Tyr (6:2:5:1)

分子量

20,000-30,000

环保替代产品得分

old score: 56
new score: 39
Find out more about DOZN™ Scoring

环保替代产品特性

Designing Safer Chemicals
Safer Solvents and Auxiliaries
Reduce Derivatives
Learn more about the Principles of Green Chemistry.

sustainability

Greener Alternative Product

颜色

white to off-white

环保替代产品分类

, Re-engineered

储存温度

−20°C

SMILES字符串

N[C@@H](CCCCN)C(=O)O.N[C@@H](Cc1ccc(cc1)O)C(=O)O.N[C@@H](CCC(=O)O)C(=O)O.N[C@@H](C)C(=O)O

InChI

1S/C9H11NO3.C6H14N2O2.C5H9NO4.C3H7NO2/c10-8(9(12)13)5-6-1-3-7(11)4-2-6;7-4-2-1-3-5(8)6(9)10;6-3(5(9)10)1-2-4(7)8;1-2(4)3(5)6/h1-4,8,11H,5,10H2,(H,12,13);5H,1-4,7-8H2,(H,9,10);3H,1-2,6H2,(H,7,8)(H,9,10);2H,4H2,1H3,(H,5,6)/t8-;5-;3-;2-/m0000/s1

InChI key

YLOCGHYTXIINAI-XKUOMLDTSA-N

相关类别

一般描述

我们竭诚为您带来满足绿色替代产品四大类别要求的替代产品。本品属于重新设计产品类别，在“设计更安全的化学品”、“更安全的溶剂和助剂”以及“减少衍生物”绿色化学原则方面取得了重大进步。 点击此处查看其 DOZN 记分卡。

生化/生理作用

聚（Ala，Glu，Lys，Tyr）6:2:5:1氢溴酸盐是一种聚氨基酸，据报道对过敏性脑脊髓炎具有抑制作用。
据报道对实验动物诱发的实验性变态反应性脑脊髓炎有抑制作用。

分析说明

基于粘度报告的分子量。

其他说明

有关聚氨基酸的其他技术信息，请访问 聚氨基酸常见问题解答资源。

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000331726
0000331726
0000276030
0000276030
SLBH2744V

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

On-line trypsin-encapsulated enzyme reactor by the sol-gel method integrated into capillary electrophoresis
Sakai-Kato, K., Kato, M. and Toyo'oka T.
Analytical Chemistry, 72, 2943-2949 (2002)
M Fridkis-Hareli et al.
Human immunology, 62(8), 753-763 (2001-07-31)
Copolymer 1 (Cop 1, poly [Y, E, A, K]) is a random synthetic amino acid copolymer effective in the treatment of relapsing forms of multiple sclerosis (MS), a disease that is linked to HLA-DR2 (DRB1*1501). In the present study various
L Jacobs et al.
Current opinion in neurology, 7(3), 250-254 (1994-06-01)
During the past year, two new agents have been demonstrated to be of value in multiple sclerosis. The first agent, a form of recombinant interferon beta (Betaseron; Berlex Labs, Cedar Knolls, NJ), is effective in reducing relapses and also prevent
Designing rational therapies for multiple sclerosis.
L Steinman et al.
Bio/technology (Nature Publishing Company), 13(2), 118-120 (1995-02-01)
The development of Cop 1 (Copaxone), an innovative drug for the treatment of multiple sclerosis: personal reflections.
R Arnon
Immunology letters, 50(1-2), 1-15 (1996-04-01)
查看所有相关文献

商品

Poly(Amino Acid) Block Copolymers for Drug Delivery and other Biomedical Applications

Humankind has utilized protein materials throughout its existence, starting with the use of materials such as wool and silk for warmth and protection from the elements and continuing with the use of recombinant DNA techniques to synthesize proteins with unique and useful properties.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门